Table 2.
Surgical details of pressurized intraperitoneal aerosol chemotherapy (PIPAC).
| Overall (n = 91) | GYN (n = 51) | Digestive (n = 40) | p value | |
|---|---|---|---|---|
| Surgical feasibility | ||||
| Number of trocars | 2 (2-3) | 2 (2-3) | 2 (2-3) | 0.668 |
| Operation time | 94 (89–108) | 91 (87–97) | 100 (92–117) | 0.002 |
| Intra-OP findings | ||||
| PCI | 10 (5–17) | 9 (4–14) | 15 (7–19) | 0.002 |
| Ascites (mL) | 50 (0–4000) | 0 (0–300) | 50 (0–4000) | 0.982 |
| Adhesiolysis | 15 (16%) | 9 (18%) | 6 (15%) | 0.735 |
| Median E-PASS | −0.20 (−0.32–−0.11) | −0.20 (−0.31–−0.10) | −0.20 (−0.31–−0.09) | 0.733 |
Median (range) for number of trocars and ascites and median (IQR) for operation time, PCI, and E-PASS. Statistical significance (p < 0.05) is highlighted in italics.
PCI: peritoneal cancer index; E-PASS: Modified Estimation of Physiologic Ability and Surgical Stress.